Skip to content

Tamoxifen

Nolvadex, Soltamox (tamoxifen) is a small molecule pharmaceutical. Tamoxifen was first approved as Nolvadex on 1982-01-01. It is used to treat breast neoplasms, gynecomastia, pancreatic neoplasms, and precocious puberty in the USA. The pharmaceutical is active against estrogen receptor. In addition, it is known to target estrogen receptor beta, G-protein coupled estrogen receptor 1, and 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase.
Trade Name Nolvadex, Soltamox
Common Name Tamoxifen
Indication breast neoplasms, gynecomastia, pancreatic neoplasms, precocious puberty
Drug Class Selective estrogen receptor modulator
Tamoxifen
Get full access now